---
document_datetime: 2025-09-05 08:57:30
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/nintedanib-viatris-epar-all-authorised-presentations_en.pdf
document_name: nintedanib-viatris-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8903365
conversion_datetime: 2025-12-17 08:28:26.895731
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Number        | (Invented) name    | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size                   |
|------------------|--------------------|------------|-----------------------|---------------------------|-----------------------|-----------------------------|
| EU/1/25/1959/001 | Nintedanib Viatris | 100 mg     | Capsule, soft         | Oral use                  | blister (alu/alu)     | 30 x 1 capsules (unit dose) |
| EU/1/25/1959/002 | Nintedanib Viatris | 100 mg     | Capsule, soft         | Oral use                  | blister (alu/alu)     | 60 x 1 capsules (unit dose) |
| EU/1/25/1959/003 | Nintedanib Viatris | 150 mg     | Capsule, soft         | Oral use                  | blister (alu/alu)     | 30 x 1 capsules (unit dose) |
| EU/1/25/1959/004 | Nintedanib Viatris | 150 mg     | Capsule, soft         | Oral use                  | blister (alu/alu)     | 60 x 1 capsules (unit dose) |